The Akkermansia Company: Danone Completes Strategic Acquisition
Deal News | Jun 25, 2025 | Innovation Industries Manageme
Innovation Industries has successfully exited its investment in The Akkermansia Company through an acquisition by global food giant Danone. The Akkermansia Company, founded in 2016, is noted for its development of the biotic strain Akkermansia muciniphila MucT™, which has been clinically proven to enhance gut barrier function and mitigate inflammation related to various metabolic disorders. This strategic acquisition will bolster Danone's expanding focus on science-backed innovations in gut health—a realm of particular interest to consumers increasingly dedicated to health and nutrition. The acquisition aligns with Danone's broader strategy to deepen its commitment to innovations that promote global health standards.
Sectors
- Biotechnology
- Food and Beverage
- Private Equity
Geography
- Europe – The Akkermansia Company was founded based on research from two European universities, and Innovation Industries is a European deeptech investor.
Industry
- Biotechnology – The Akkermansia Company operates in the biotechnology sector, focusing on the development of a next-generation biotic strain.
- Food and Beverage – Danone is a major player in the food and beverage industry, particularly in health-focused products, which relates to their acquisition of The Akkermansia Company.
- Private Equity – Innovation Industries, a private equity firm, is involved in the investment and exit from The Akkermansia Company.
Financials
Participants
Name | Role | Type | Description |
---|---|---|---|
Innovation Industries | Selling Company (Vendor) | Company | A leading European deeptech investor specializing in innovative, technology-driven companies. |
Danone | Bidding Company (Buyer) | Company | A global food giant focusing on expanding its portfolio in health and nutrition. |
The Akkermansia Company | Target Company | Company | A biotechnology company known for its development of the Akkermansia muciniphila MucT™ strain. |
UC Louvain | Research Institution | Institution | One of the European universities involved in the research that led to the founding of The Akkermansia Company. |
Wageningen University | Research Institution | Institution | A key research partner in the development of The Akkermansia Company's biotic strain. |